News

Christine Yu Moutier, MD, discusses suicide prevention strategies, highlighting risk factors and the importance of culturally competent care for vulnerable populations.

Today is World Suicide Prevention Day. Media training emerges as a vital tool for psychiatrists, enhancing suicide prevention efforts and combating misinformation in mental health.

New research reveals ART12.11, a cannabidiol:tetramethylpyrazine cocrystal, significantly enhances mood regulation, outperforming traditional cannabidiol in treating mood and anxiety disorders.

Explore the complexities of geriatric psychiatry, addressing mental health challenges in aging populations with expert insights and practical strategies.

Alto Neuroscience reveals EEG biomarkers effectively distinguish patients with schizophrenia, enhancing treatment precision and advancing psychiatric research.

What do you do when a patient, who is also a physician, disagrees? A psychiatrist navigates complex mental health challenges, rejecting a bipolar diagnosis while advocating for patient autonomy and addressing stigma in health care.

Tonmya, the first new FDA-approved fibromyalgia treatment in 15 years, shows promise in reducing pain and improving patient outcomes according to newly released data.

FDA approves Amneal Pharmaceuticals' new long-acting injectable risperidone for schizophrenia, enhancing treatment options and potentially patient adherence.

Explore the evolving perceptions and treatments of sexual deviance, particularly pedophilia, from historical views to modern psychiatric approaches.

Alixorexton shows promise as a treatment for narcolepsy type 1, and is the first orexin 2 receptor agonist to demonstrate clinically meaningful and statistically significant impact on wakefulness, cognition, and fatigue with once-daily dosing across a range of doses.

Chatbots pose significant risks for individuals with eating disorders, often promoting harmful behaviors and misinformation while lacking proper safety measures.

Explore the impact of moral injuries on mental health professionals, highlighting the urgent need for attention and support in today's health care landscape.

Psychiatrists confront the challenge of treatment-resistant depression, balancing honesty and compassion while redefining realistic recovery goals for patients.

Cannabis use among older adults surges as they seek relief from pain and anxiety, prompting clinicians to navigate complex treatment challenges.

Postoperative delirium often goes unrecognized, especially in older patients, leading to significant cognitive decline and longer hospital stays.

Explore the profound impact of relationships over achievements as we reflect on legacy and the importance of family connections in later life.

Remembering Robert Jay Lifton, MD

Explore the powerful memoirs of Kay Redfield Jamison, offering profound insights into living with bipolar disorder and the complexities of love.

Exploring the prevalence and implications of psychotropic polypharmacy in patients taking clozapine with treatment-resistant schizophrenia.

Neuroplasticity enables the brain to adapt and recover after injury, emphasizing the importance of multidisciplinary rehabilitation for effective healing.

Neuphoria Therapeutics announces successful enrollment in a pivotal trial for BNC-210, a promising treatment for social anxiety disorder.

Explore the intersection of technology and memory as holograms of genocide survivors inspire hope and healing in today's world.

Read the exclusive August Special Report on issues in diversity!

Explore the complex interplay of genetics, environment, concussion, substance abuse, and inflammation in severe mental illnesses, revealing critical insights for prevention and treatment.

Achieve Life Sciences gains FDA acceptance for cytisinicline, a promising new drug for smoking cessation, showing significant abstinence rates in trials.

A new guideline from the APA enhance the prevention and treatment of delirium, aiming to improve patient care and outcomes in clinical settings.

Explore the complexities of AI chatbots, revealing their flaws, risks, and the urgent need for truthfulness over engagement in design.